FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease

Article Link: FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease

VIENNA, VA. (PRWEB) JUNE 21, 2021 Sarfez Pharmaceuticals announced today approval by the U.S. Food and Drug Administration (FDA) of the Virginia-based company’s New Drug Application for Soaanz, a once-a-day improved formulation of the loop…

Source: FDA New Drug Approvals